DocGo Q3 adjusted EBITDA beats analyst expectations on  business lines restructuring

By Reuters News


Overview

  • US mobile health and transport firm's Q3 revenue rose yr/yr but missed analyst expectations

  • Q3 adjusted EBITDA loss narrowed and beat analyst expectations

  • Gross margin improved 280 bps over Q2 driven by profitability initiatives


Outlook

  • Company lowers full-year 2026 revenue outlook to $300 mln from $305-$310 mln

  • Company maintains full-year 2026 adjusted EBITDA guidance at ($17)-($22) mln

  • Company expects improved margins and increased volumes as patient outreach ramps up


Result Drivers

  • BUSINESS LINE RESTRUCTURING - Co said elimination and restructuring of unprofitable business lines drove improved margins and narrowed adjusted EBITDA loss

  • COST OPTIMIZATION - Co attributed margin improvement to profitability initiatives, including cost controls, despite higher fuel costs

  • VOLUME GROWTH IN CORE SEGMENTS - Co reported record volumes in medical transportation, mobile phlebotomy, and remote monitoring


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$73.4 mln

$77.19 mln (5 Analysts)

Q3 Net Loss

$18.29 mln

Q3 Adjusted EBITDA

Beat

-$3.2 mln

-$4.43 mln (5 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for DocGo Inc. is $1.75, about 614.3% above its November 6 closing price of $0.25


Reuters Recommended Reads

  • Nov 9 - Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion

  • Nov 8 - RadNet beats Q3 adjusted EPS estimates, lifts 2026 outlook

  • Nov 9 - US FDA orders new eye risk warnings for Ozempic, Zepbound


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk